Nitisinone is an example of
Enzyme activation therapy
Enzyme replacement therapy
Substrate addition therapy
Substrate reduction therapy
Nitisinone is prescribed for infantile tyrosinemia because it decreases production of the substrate (fumarylacetoacetate) for the hydrolase, thus decreasing the velocity of the reaction preventing substrate accumulation.
Phenylalanine and Tyrosine metabolism Detail